adenylate cyclase

adenylate cyclase Adenylate cyclase is an enzyme that catalyzes conversion of ATP to cyclic AMP (cAMP) and pyrophosphate, acting as a pivotal signal transducer in many cells and tissues. First characterized in studies linked to Sir Hans Krebs-era metabolism and later explored in receptor pharmacology associated with Alfred G. Gilman and Martin Rodbell, it connects extracellular stimuli from G protein-coupled receptors and other inputs to intracellular effectors such as Protein kinase A and Exchange protein directly activated by cAMP (EPAC). Its discovery and characterization influenced modern understanding of second messenger systems and earned related investigators major recognition in awards like the Nobel Prize in Physiology or Medicine.

Introduction

Adenylate cyclase was central to foundational experiments in biochemistry and pharmacology that elucidated how ligands at membrane receptors produce intracellular responses via second messengers; these experiments intersected with research programs at institutions such as National Institutes of Health and Harvard University. Historically, work on adenylate cyclase informed studies in endocrinology (e.g., glucagon and epinephrine signaling) and in neuroscience through neurotransmitters like dopamine and serotonin. The enzyme’s role spans organisms from Escherichia coli and Bacillus subtilis in microbiology to mammalian systems investigated in laboratories at University of Cambridge and Stanford University.

Structure and isoforms

Adenylate cyclases comprise multiple families and isoforms with distinct structural motifs characterized by biochemical and crystallographic studies carried out at centers including Max Planck Society and European Molecular Biology Laboratory. In mammals, the membrane-bound class I adenylyl cyclases include at least nine isoforms (AC1–AC9) encoded by genes studied at institutions like National Cancer Institute and Sanger Institute, each exhibiting tissue-specific expression in organs such as brain regions studied at Massachusetts Institute of Technology and Johns Hopkins University Hospital. Soluble adenylate cyclase (sAC) is a distinct class encoded by a separate gene and has been analyzed in contexts related to mitochondria and spermatozoa function; structural characterization involved collaborations between groups at University of California, San Francisco and ETH Zurich. Domains responsible for catalysis derive from conserved catalytic core residues identified by comparisons to bacterial cyclases in species like Mycobacterium tuberculosis and inferred from structures deposited by laboratories affiliated with Protein Data Bank contributors. Isoform-specific regulatory regions interact with proteins studied in proteomics efforts at European Bioinformatics Institute and Cold Spring Harbor Laboratory.

Mechanism and regulation

Catalysis proceeds via conversion of ATP to cyclic AMP through a two-metal ion mechanism elucidated in structural work influenced by researchers at California Institute of Technology and Yale University. Membrane-associated isoforms are regulated primarily by heterotrimeric G proteins (Gαs stimulates, Gαi inhibits), with molecular detail derived from studies led by investigators at Columbia University and Rockefeller University. Receptor coupling involves G protein-coupled receptor families such as the β-adrenergic receptor and muscarinic acetylcholine receptor, linking extracellular ligands like adrenaline and acetylcholine to AC activity; these pathways have been probed in pharmacology departments at University of Oxford and University of Tokyo. Calcium-calmodulin modulation, phosphorylation by kinases such as Protein kinase C and CaMKII, and direct regulation by small molecules like forskolin (from Plectranthus species) or bicarbonate for sAC provide multi-modal control, topics explored in projects at Scripps Research and Karolinska Institutet.

Physiological roles and signaling pathways

Adenylate cyclase-generated cAMP activates effectors including Protein kinase A, EPAC, and cyclic nucleotide-gated channels, thereby regulating processes studied in disciplines such as cardiology (heart rate control via β-adrenergic signaling), otolaryngology (inner ear hair cell function), and endocrinology (insulin and glucagon balance). In the central nervous system, AC isoforms contribute to synaptic plasticity mechanisms relevant to long-term potentiation researched at University College London and memory studies linked to Howard Hughes Medical Institute investigators. cAMP signaling intersects with pathways regulated by MAP kinase cascades and phosphodiesterase families catalogued by consortia like PharmGKB; cross-talk with cGMP signaling has implications in vascular biology and drugs developed by companies such as Pfizer and Novartis. In reproduction, sAC-dependent cAMP synthesis is essential for sperm capacitation investigated in reproductive biology labs at University of Sydney and University of Milan.

Clinical significance and pharmacology

Dysregulation of adenylate cyclase or cAMP signaling is implicated in diseases including certain heart failure phenotypes, psychiatric disorders researched at National Institute of Mental Health, and infectious diseases where pathogens such as Bordetella pertussis produce toxins that alter G protein regulation. Pharmacological modulation includes agonists (e.g., forskolin) and inhibitors, along with indirect targeting through β-blockers and phosphodiesterase inhibitors developed in industrial research at GlaxoSmithKline and AstraZeneca. Genetic variations in AC isoform genes have been associated with susceptibility to conditions studied in genome-wide association studies led by consortia at Wellcome Trust and 10x Genomics. Therapeutic strategies aim to exploit isoform-selective modulation to treat asthma, heart failure, and neuropsychiatric disorders, with clinical trials conducted through networks including ClinicalTrials.gov investigators and academic medical centers such as Mayo Clinic.

Category:Enzymes